| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Common Stock, par value $0.0001 per share | 13.8% | $3.9M | $554K | 6.4M | +16.6% | Vaddi Krishna | Mar 31, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|